Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Recombinant human growth hormone: Phase I

In an cross-over Phase I trial in 12 healthy volunteers, a single dose

Read the full 130 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE